Cinflumide

Icilin is a synthetic cooling agent and modulates human transient receptor potential cation channel (TRPA1). Icilin inhibits transient receptor potential cation channel subfamily M member 8 (TRPM8) and modulates calcium release.

Icilin is a synthetic cooling agent and modulates human transient receptor potential cation channel (TRPA1). Icilin inhibits transient receptor potential cation channel subfamily M member 8 (TRPM8) and modulates calcium release.

Immunotag™ Rat Ciliary neurotrophic factor ELISA Kit

Recombinant, human interleukin-10 expressed in S. frugiperda insect cells.

NEUROFILAMENT (2F11) 0.1ML CONCENTRATE

NEUROFILAMENT (2F11) 0.5ML CONCENTRATE

PF-04745637 is a potent and selective TRPA1 antagonist with an IC 50 of 17 nM for human TRPA1In VivoTopically applied PF-04745637 (Compound 8: 50 mg/mL and 100 mg/mL) significantly reduces cinnamaldehyde-mediated flare in rat skin . MCE has not

PF-04745637 is a potent and selective TRPA1 antagonist with an IC 50 of 17 nM for human TRPA1In VivoTopically applied PF-04745637 (Compound 8: 50 mg/mL and 100 mg/mL) significantly reduces cinnamaldehyde-mediated flare in rat skin . MCE has not

PF-04745637 is a potent and selective TRPA1 antagonist with an IC 50 of 17 nM for human TRPA1In VivoTopically applied PF-04745637 (Compound 8: 50 mg/mL and 100 mg/mL) significantly reduces cinnamaldehyde-mediated flare in rat skin . MCE has not

Quizartinib (AC220) is a second-generation FLT3 inhibitor for Flt3(ITD/WT) with IC50 of 1.1 nM/4.2 nM, 10-fold more selective for Flt3 than KIT, PDGFRα, PDGFRβ, RET, and CSF-1R. Phase 3.An Flt-3/Flk-2 inhibitor.

Quizartinib (AC220) is a second-generation FLT3 inhibitor for Flt3(ITD/WT) with IC50 of 1.1 nM/4.2 nM, 10-fold more selective for Flt3 than KIT, PDGFRα, PDGFRβ, RET, and CSF-1R. Phase 3.An Flt-3/Flk-2 inhibitor.

Rival CR&rsquos new soft modulus nitrile delivers the fit and feel of latex for the ultimate stretch and comfort. Suitable for cleanroom, pharmaceutical, biotech and medical device manufacturing.